Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ENTX holding history

Entera Bio Ltd. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENTX overviewAll 13F holders of ENTXFull Q2 2026 holdings

Shares (Q2 2026)
12,723
Value
$22.5K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of ENTX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,723$22.5K<0.1%+9,511+296.1%AddedHolders
Q1 20263,212$3.56K<0.1%+3,195+18,794.1%AddedHolders
Q4 202517$33<0.1%−10,435−99.8%ReducedHolders
Q3 202510,452$20.1K<0.1%−5,179−33.1%ReducedHolders
Q2 202515,631$29.7K<0.1%+15,631NewHolders
Q4 20240$00.0%−142,747−100.0%Sold outHolders
Q3 2024142,747$271.2K<0.1%−24,876−14.8%ReducedHolders
Q2 2024167,623$308.4K<0.1%+17,754+11.8%AddedHolders
Q1 2024149,869$250.3K<0.1%+149,869NewHolders
Q4 20230$00.0%−614−100.0%Sold outHolders
Q3 2023614$445<0.1%−450−42.3%ReducedHolders
Q2 20231,064$897<0.1%−8,676−89.1%ReducedHolders
Q1 20239,740$11.3K<0.1%−648−6.2%ReducedHolders
Q4 202210,388$7.58K<0.1%+8,634+492.2%AddedHolders
Q3 20221,754$2.00K<0.1%−5,650−76.3%ReducedHolders
Q2 20227,404$10.0K<0.1%+2,744+58.9%AddedHolders
Q1 20224,660$13.0K<0.1%+4,660NewHolders
Q4 20210$00.0%−565−100.0%Sold outHolders
Q3 2021565$3.00K<0.1%−457−44.7%ReducedHolders
Q2 20211,022$6.00K<0.1%−592−36.7%ReducedHolders
Q1 20211,614$6.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.